Gelonghui October 8th | Virios Therapeutics soared more than 33% to $0.183 before the market opened. The company announced on Monday that it has reached a definitive stock trade agreement to merge with another subsidiary of Kangyi Life Sciences International Limited company, Wex Pharmaceuticals, in an all-stock trade deal. Virios will be renamed Dogwood Therapeutics starting from Wednesday.
美股异动丨virios therapeutics盘前涨超33% 已与Wex Pharmaceuticals达成明确合并协议
Stocks in the United States | virios therapeutics surged more than 33% pre-market, has reached a clear merger agreement with Wex Pharmaceuticals.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated